Pharmacogenomics Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacogenomics, including details on pharmacology, designer drugs, customized medicines.

Volume 1 (2005), Issue 2 (November)

1. Combinatorial pharmacogenetics.
   Nat Rev Drug Discov, 4(11): 911-8. [Abstract] [Full-text]
2. Pharmacogenomics of statin responsiveness.
   Am J Cardiol, 96(9): 65K-70K; discussion 34K-35K. [Abstract] [Full-text]
3. Implications of pharmacogenomics for drug development and clinical practice.
   Arch Intern Med, 165(20): 2331-6. [Abstract] [Full-text]
4. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.
   Clin Cancer Res, 11(22): 8097-104. [Abstract] [Full-text]
5. Pharmacogenetics and anesthesiologists.
   Pharmacogenomics, 6(8): 849-56. [Abstract] [Full-text]
6. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.
   Pharmacogenomics, 6(8): 823-34. [Abstract] [Full-text]
7. Individualised cancer therapeutics: dream or reality?
   Expert Opin Ther Targets, 9(6): 1189-201. [Abstract] [Full-text]
8. Racializing drug design: implications of pharmacogenomics for health disparities.
   Am J Public Health, 95(12): 2133-8. [Abstract] [Full-text]
9. Pharmacogenetics of colorectal cancer.
   Expert Opin Pharmacother, 6(15): 2607-16. [Abstract] [Full-text]
10. Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?
    Expert Opin Pharmacother, 6(15): 2593-605. [Abstract] [Full-text]
11. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
    Expert Opin Pharmacother, 6(15): 2577-91. [Abstract] [Full-text]
12. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Expert Opin Pharmacother, 6(15): 2565-76. [Abstract] [Full-text]

© 2005-2008 Pharmacogenomics Research Today. All Rights Reserved.